MXPA03008393A - Derivados de guanidina biciclicos y usos terapeuticos de los mismos. - Google Patents

Derivados de guanidina biciclicos y usos terapeuticos de los mismos.

Info

Publication number
MXPA03008393A
MXPA03008393A MXPA03008393A MXPA03008393A MXPA03008393A MX PA03008393 A MXPA03008393 A MX PA03008393A MX PA03008393 A MXPA03008393 A MX PA03008393A MX PA03008393 A MXPA03008393 A MX PA03008393A MX PA03008393 A MXPA03008393 A MX PA03008393A
Authority
MX
Mexico
Prior art keywords
therapeutic uses
guanidine derivatives
bicyclic guanidine
bicyclic
derivatives
Prior art date
Application number
MXPA03008393A
Other languages
English (en)
Inventor
Gerard Moinet
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA03008393A publication Critical patent/MXPA03008393A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/06Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/08Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA03008393A 2001-03-21 2002-02-27 Derivados de guanidina biciclicos y usos terapeuticos de los mismos. MXPA03008393A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0103843A FR2822463B1 (fr) 2001-03-21 2001-03-21 Derives bicycliques de guanidines et leurs applications en therapeutique
PCT/EP2002/002094 WO2002076963A1 (en) 2001-03-21 2002-02-27 Bicyclic guanidine derivatives and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
MXPA03008393A true MXPA03008393A (es) 2004-01-29

Family

ID=8861404

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03008393A MXPA03008393A (es) 2001-03-21 2002-02-27 Derivados de guanidina biciclicos y usos terapeuticos de los mismos.

Country Status (23)

Country Link
US (1) US7491733B2 (es)
EP (1) EP1370542B1 (es)
JP (1) JP2004525146A (es)
KR (1) KR20030086312A (es)
CN (1) CN1229362C (es)
AR (1) AR035698A1 (es)
AU (1) AU2002254911B2 (es)
BR (1) BR0208109A (es)
CA (1) CA2441331C (es)
CZ (1) CZ20032765A3 (es)
EE (1) EE200300454A (es)
ES (1) ES2518315T3 (es)
FR (1) FR2822463B1 (es)
HK (1) HK1061562A1 (es)
HU (1) HUP0303612A3 (es)
IL (1) IL158001A0 (es)
MX (1) MXPA03008393A (es)
NO (1) NO20034172L (es)
PL (1) PL362657A1 (es)
RU (1) RU2282622C2 (es)
SK (1) SK12812003A3 (es)
WO (1) WO2002076963A1 (es)
ZA (1) ZA200308145B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE466013T1 (de) 2004-09-03 2010-05-15 Yuhan Corp Pyrroloä3,2-cüpyridinderivate und verfahren zu deren herstellung
DE102005034269A1 (de) * 2005-07-22 2007-01-25 Lanxess Deutschland Gmbh Halogenfreie, flammwidrige Polyurethanschaumstoffe
EP2046753A2 (en) 2006-07-06 2009-04-15 Brystol-Myers Squibb Company Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
EA022623B1 (ru) 2010-10-06 2016-02-29 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Производные бензимидазола в качестве ингибиторов pi3-киназ
RU2711098C1 (ru) * 2019-04-15 2020-01-15 Федеральное государственное бюджетное научное учреждение "Федеральный Ростовский аграрный научный центр" (ФГБНУ ФРАНЦ) Производные нитропиридина, обладающие антибактериальной и протистоцидной активностью
CN113967210A (zh) * 2020-07-24 2022-01-25 上海交通大学医学院附属瑞金医院 一种干扰整合素β3/Src相互作用的化合物的用途
CN113968855A (zh) * 2020-07-24 2022-01-25 中国科学院上海药物研究所 一种治疗血栓性疾病的化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3428653A (en) * 1965-06-28 1969-02-18 Sterling Drug Inc 3-indolylmethylguanidine
GB1148214A (en) * 1965-11-26 1969-04-10 Ward Blenkinsop & Co Ltd Heterocyclic guanidine derivatives
US3855242A (en) * 1967-12-15 1974-12-17 Aspro Nicholas Ltd Benzo{8 b{9 thienyl-alkyl-guanidines
US3700697A (en) * 1968-04-22 1972-10-24 Sterling Drug Inc (2,3-dihydro-2-benzofuranylmethyl) guanidines and their preparation
DE2739723A1 (de) * 1977-09-03 1979-03-08 Merck Patent Gmbh 2-guanidinomethyl-indoline und verfahren zu ihrer herstellung
CA2011899A1 (en) * 1989-03-13 1990-09-13 Masaaki Toda Benzopyran derivatives
WO1991009023A1 (en) 1989-12-11 1991-06-27 American Home Products Corporation N-heteroaralkyl-substituted 1-aryloxy-2-propanolamine and propylamine derivatives possessing class iii antiarrhythmic activity
JPH07503970A (ja) 1992-02-19 1995-04-27 ジ・アップジョン・カンパニー CNS活性を有する3−置換イミダゾ(1,5−a)−キノキサリン類およびキナゾリン類
SE9301912D0 (sv) 1993-06-03 1993-06-03 Ab Astra Process for the production of aminoalkylguandines
CN1114834A (zh) 1993-09-28 1996-01-10 大塚制药株式会社 抗糖尿病剂
AU702661B2 (en) 1994-06-29 1999-02-25 Smithkline Beecham Corporation Vitronectin receptor antagonists
US5955495A (en) 1996-05-03 1999-09-21 Hoffmann-La Roche Inc. Method of treating diseases of the CNS
US6072075A (en) 1997-05-22 2000-06-06 The Regents Of The University Of California Guanidinylation reagents

Also Published As

Publication number Publication date
ZA200308145B (en) 2005-01-20
FR2822463B1 (fr) 2004-07-30
PL362657A1 (en) 2004-11-02
AR035698A1 (es) 2004-06-23
EE200300454A (et) 2003-12-15
ES2518315T3 (es) 2014-11-05
EP1370542B1 (en) 2014-08-20
US20040122040A1 (en) 2004-06-24
CN1229362C (zh) 2005-11-30
BR0208109A (pt) 2004-03-02
CA2441331C (en) 2010-10-05
KR20030086312A (ko) 2003-11-07
AU2002254911B2 (en) 2007-09-06
FR2822463A1 (fr) 2002-09-27
HUP0303612A3 (en) 2005-02-28
NO20034172D0 (no) 2003-09-19
CA2441331A1 (en) 2002-10-03
CN1498214A (zh) 2004-05-19
NO20034172L (no) 2003-09-19
WO2002076963A1 (en) 2002-10-03
CZ20032765A3 (cs) 2004-01-14
RU2003130062A (ru) 2005-04-10
IL158001A0 (en) 2004-03-28
RU2282622C2 (ru) 2006-08-27
SK12812003A3 (sk) 2004-02-03
US7491733B2 (en) 2009-02-17
EP1370542A1 (en) 2003-12-17
HUP0303612A2 (hu) 2004-03-01
HK1061562A1 (en) 2004-09-24
JP2004525146A (ja) 2004-08-19

Similar Documents

Publication Publication Date Title
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
HK1064090A1 (en) Xanthine derivative, production and use thereof asa medicament
IL161384A0 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
HK1076110A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2002359126A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2002359123A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
PT1525193E (pt) Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide
HK1074444A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
MXPA03008393A (es) Derivados de guanidina biciclicos y usos terapeuticos de los mismos.
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
IL161859A0 (en) 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
ATA17852001A (de) Signaturarmer und schadstoffreduzierter, pyrotechnischer darstellungskörper
SI1363885T1 (sl) Substituirani derivati propan-1,3-diamina in njihova farmacevtska uporaba
IL158435A0 (en) Polypeptides, derivatives and uses thereof
IL156593A0 (en) Mikanolide derivatives, their preparation and therapeutic uses
SI1525193T1 (sl) Acilaminotiazolni derivati in njihova uporaba kotinhibitorji beta-amiloida
SI1525198T1 (sl) Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP
SI1513836T1 (sl) Derivati piperazinilacilpiperidina, njihova priprava in njihova terapevtska uporaba
SI1513835T1 (sl) Derivati piperazunilacilpiperidina, njihova priprava in njihova terapevtska uporaba
AU2002319163A1 (en) Cyanoanthranilamide derivatives and the use thereof as medicaments